Screening assays for tyrosine kinase inhibitors: A review

Juan Gao1, Jingyi Jian1, Zhengjin Jiang2

  • 1Institute of Pharmaceutical Analysis/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, College of Pharmacy, Jinan University, Guangzhou 510632, China; KU Leuven - University of Leuven, Pharmaceutical Analysis, Department of Pharmaceutical and Pharmacological Sciences, O&N2, PB 923, Herestraat 49, 3000 Leuven, Belgium.

Insights

This review explores assays for discovering tyrosine kinase inhibitors, crucial for targeting cell growth and proliferation in diseases like cancer. It details various screening technologies to identify new therapeutic agents.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Tyrosine kinases regulate critical cellular processes like growth and differentiation.
  • Dysregulated tyrosine kinase activity is implicated in numerous disease pathologies.
  • Targeting tyrosine kinases is a key strategy in developing therapeutics, particularly for cancer.

Purpose of the Study:

  • To review and compare various assay technologies for identifying novel tyrosine kinase inhibitors.
  • To provide insights into the principles, advantages, and disadvantages of different screening methods.
  • To guide researchers in selecting appropriate assays for exploring new tyrosine kinase inhibitor drug candidates.

Main Methods:

  • Review of established and advanced assay technologies for tyrosine kinase inhibitor screening.
  • Discussion of filtration binding assays, scintillation proximity assays, and high-throughput screening methods.
  • Analysis of the merits, demerits, and applications of diverse technological approaches.

Main Results:

  • Multiple assay technologies exist for tyrosine kinase inhibitor discovery, each with unique characteristics.
  • Traditional and high-throughput methods offer different balances of throughput, cost, and information.
  • The choice of assay depends on specific research goals and available resources.

Conclusions:

  • A comprehensive understanding of available assays is essential for efficient tyrosine kinase inhibitor exploration.
  • Advancements in screening technologies continue to enhance the discovery of targeted cancer therapies.
  • This review serves as a guide to navigating the landscape of tyrosine kinase inhibitor screening assays.